HIV vulnerability among adolescent girls and young women: a multi-country latent class analysis approach.


Journal

International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551

Informations de publication

Date de publication:
May 2020
Historique:
received: 03 06 2019
accepted: 11 03 2020
revised: 06 02 2020
pubmed: 10 4 2020
medline: 18 11 2020
entrez: 10 4 2020
Statut: ppublish

Résumé

To stem the HIV epidemic among adolescent girls and young women (AGYW, 15-24 years), prevention programs need to reach AGYW who are most at risk. We examine whether individual- and household-level factors could be used to define HIV vulnerability for AGYW. We surveyed out-of-school AGYW in urban and peri-urban Kenya (N = 1014), in urban Zambia (N = 846), and in rural Malawi (N = 1654) from October 2016 to 2017. LCA identified classes based on respondent characteristics, attitudes and knowledge, and household characteristics. Multilevel regressions examined associations between class membership and HIV-related health outcomes. We identified two latent classes-high and low HIV vulnerability profiles-among AGYW in each country; 32% of the sample in Kenya, 53% in Malawi, and 51% in Zambia belonged to the high vulnerability group. As compared to AGYW with a low-vulnerability profile, AGYW with a high-vulnerability profile had significantly higher odds of HIV-related outcomes (e.g., very early sexual debut, transactional sex, sexual violence from partners). Out-of-school AGYW had differential vulnerability to HIV. Interventions should focus on reaching AGYW in the high HIV vulnerability profiles.

Identifiants

pubmed: 32270233
doi: 10.1007/s00038-020-01350-1
pii: 10.1007/s00038-020-01350-1
pmc: PMC7274997
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-411

Subventions

Organisme : Bill and Melinda Gates Foundation
ID : OPP1136778

Références

Stud Fam Plann. 2018 Dec;49(4):367-383
pubmed: 30478973
AIDS. 2008 Mar 30;22(6):759-66
pubmed: 18356606
J Infect Dis. 2005 Feb 1;191 Suppl 1:S61-7
pubmed: 15627232
J Adolesc Health. 2011 Dec;49(6):559-67
pubmed: 22098766
PLoS One. 2018 Dec 7;13(12):e0208167
pubmed: 30532210
Health Policy Plan. 2016 Jul;31(6):729-35
pubmed: 26701916
Health Care Women Int. 2017 Sep;38(9):927-944
pubmed: 28586273
J Adolesc Health. 2019 Dec;65(6):730-737
pubmed: 31543406
Glob Soc Welf. 2015 Jun;2(2):87-103
pubmed: 26075159
J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):393-400
pubmed: 23535293
Int J Womens Health. 2017 Sep 28;9:727-737
pubmed: 29033613
J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):53-63
pubmed: 28991885
AIDS. 2017 Jul 01;31 Suppl 3:S195-S201
pubmed: 28665877
J Adolesc Health. 2017 Feb;60(2S2):S15-S21
pubmed: 28109335
Gates Open Res. 2018 Dec 11;2:68
pubmed: 31131368
Am J Public Health. 2009 Dec;99(12):2224-9
pubmed: 19833992
Curr HIV/AIDS Rep. 2015 Jun;12(2):207-15
pubmed: 25855338
AIDS Behav. 2018 Jun;22(6):1858-1869
pubmed: 28161801
Lancet. 2010 Jul 3;376(9734):41-8
pubmed: 20557928
J Adolesc Health. 2015 Jan;56(1 Suppl):S15-21
pubmed: 25528976
J Acquir Immune Defic Syndr. 2016 May 1;72(1):96-104
pubmed: 26825176

Auteurs

Sanyukta Mathur (S)

Population Council, 4301 Connecticut Ave, Suite 280, Washington, DC, USA. smathur@popcouncil.org.

Nanlesta Pilgrim (N)

Independent Consultant, Washington, DC, USA.

Sangram Kishor Patel (SK)

Population Council, New Delhi, India.

Jerry Okal (J)

Population Council, Nairobi, Kenya.

Victor Mwapasa (V)

Centre for Reproductive Health, College of Medicine, Blantyre, Malawi.

Effie Chipeta (E)

Centre for Reproductive Health, College of Medicine, Blantyre, Malawi.

Maurice Musheke (M)

Independent Consultant, Lusaka, Zambia.

Bidhubhusan Mahapatra (B)

Population Council, New Delhi, India.

Julie Pulerwitz (J)

Population Council, 4301 Connecticut Ave, Suite 280, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH